Spacer Graft Study
Eyelid Diseases, Eyelid Droop
About this trial
This is an interventional treatment trial for Eyelid Diseases focused on measuring Retraction Repair, Hard Palate, Autologous Ear Cartilage, porcine acellular dermal matrix, spacer graft
Eligibility Criteria
Inclusion Criteria:
- Patients will be included if they undergo lower eyelid retraction repair requiring a spacer graft between July 1, 2019 and July 1, 2022 .
Exclusion Criteria:
- Patients will be excluded if they are younger than 18 years old, required concurrent surgeries (e.g., midface lift or full thickness skin graft) or required further surgeries on the operated eyelid within the 6 months postoperatively. In addition, patients with less than 1-month follow up will be excluded from all outcome analysis and those without postoperative 6-month data will be excluded from the postoperative month 6 MRD2 calculation.
Sites / Locations
- Montefiore Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Active Comparator
Hard Palate
Autologous Ear Cartilage
Porcine Acellular Dermal Matrix
Some patients who will already be undergoing lower eyelid retraction repair with a spacer graft will be randomized to use hard palate
Some patients who will already be undergoing lower eyelid retraction repair with a spacer graft will be randomized to use autologous ear cartilage
Some patients who will already be undergoing lower eyelid retraction repair with a spacer graft will be randomized to use porcine acellular dermal matrix